Literature DB >> 21222023

Quality of life assessment in patients with neurocysticercosis.

Sergio Monteiro de Almeida1, Solange Aparecida Gurjão.   

Abstract

Objective of this study to investigate the impact of NCC upon the quality of life (QoL) compared to other chronic neurological diseases, epilepsy and headache. The study group consisted of 114 patients subdivided into four groups: NCC with epilepsy (n = 48), NCC without epilepsy (n = 17), epilepsy without NCC (n = 25) and chronic headache (n = 24). The QoL was evaluated by direct subjective quantification (scale of 0-10) and FACT-HN IV. NCC had impact on QoL, 53.8% patients dependent and needing help. The impact on QoL did not correlate with the classification of NCC, presence of cysts or calcifications and with CSF TP or number of WBCs. The presence of depression had a significant impact on the QoL of patients with NCC. Lack of seizure control tended to produce an adverse effect on the QoL in the group of NCC and epilepsy. NCC is not a benign disease; it has greater adverse effects on QoL of patients than epilepsy and headache, although without statistical significance. The presence of depression and uncontrolled seizures may have impact on QoL. Since asymptomatic patients were not evaluated, the results of this study are not applicable to all individuals with NCC.

Entities:  

Mesh:

Year:  2011        PMID: 21222023     DOI: 10.1007/s10900-010-9351-5

Source DB:  PubMed          Journal:  J Community Health        ISSN: 0094-5145


  30 in total

1.  Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.

Authors:  I M Anderson
Journal:  J Affect Disord       Date:  2000-04       Impact factor: 4.839

2.  Neurocysticercosis in the United States: review of an important emerging infection.

Authors:  Christopher M DeGiorgio; Frank Sorvillo; Susan Pietsch Escueta
Journal:  Neurology       Date:  2005-04-26       Impact factor: 9.910

3.  Epilepsy and society.

Authors:  H M de Boer
Journal:  Epilepsia       Date:  1995       Impact factor: 5.864

4.  Psychiatric manifestations of neurocysticercosis: a study of 38 patients from a neurology clinic in Brazil.

Authors:  O V Forlenza; A H Filho; J P Nobrega; L dos Ramos Machado; N G de Barros; C H de Camargo; M F da Silva
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-06       Impact factor: 10.154

5.  Quality of life in cancer patients--an hypothesis.

Authors:  K C Calman
Journal:  J Med Ethics       Date:  1984-09       Impact factor: 2.903

Review 6.  Proposed diagnostic criteria for neurocysticercosis.

Authors:  O H Del Brutto; V Rajshekhar; A C White; V C Tsang; T E Nash; O M Takayanagui; P M Schantz; C A Evans; A Flisser; D Correa; D Botero; J C Allan; E Sarti; A E Gonzalez; R H Gilman; H H García
Journal:  Neurology       Date:  2001-07-24       Impact factor: 9.910

7.  Is dementia reversible in patients with neurocysticercosis?

Authors:  J Ramirez-Bermudez; J Higuera; A L Sosa; E Lopez-Meza; M Lopez-Gomez; T Corona
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-08       Impact factor: 10.154

Review 8.  [Clinical manifestations of neurocysticercosis].

Authors:  D San-juan Orta
Journal:  Neurologia       Date:  2009-06       Impact factor: 3.109

9.  What things are important in people's lives? A survey of the public's judgements to inform scales of health related quality of life.

Authors:  A Bowling
Journal:  Soc Sci Med       Date:  1995-11       Impact factor: 4.634

10.  Measuring the impact of epilepsy: the development of a novel scale.

Authors:  A Jacoby; G Baker; D Smith; M Dewey; D Chadwick
Journal:  Epilepsy Res       Date:  1993-09       Impact factor: 3.045

View more
  4 in total

1.  Neurocysticercosis--retrospective study of autopsy reports, a 17-year experience.

Authors:  Sérgio Monteiro de Almeida; Luiz Fernando Bleggi Torres
Journal:  J Community Health       Date:  2011-10

2.  The effect of albendazole treatment on non-seizure outcomes in patients with symptomatic neurocysticercosis.

Authors:  Kriti Thapa; Matthew L Romo; Arturo Carpio; Denise Leslie; Howard Andrews; W Allen Hauser; Elizabeth A Kelvin
Journal:  Trans R Soc Trop Med Hyg       Date:  2018-02-01       Impact factor: 2.184

3.  Association between Taenia solium infection and HIV/AIDS in northern Tanzania: a matched cross sectional-study.

Authors:  Veronika Schmidt; Christian Kositz; Karl-Heinz Herbinger; Hélène Carabin; Bernard Ngowi; Ezra Naman; Patricia P Wilkins; John Noh; William Matuja; Andrea Sylvia Winkler
Journal:  Infect Dis Poverty       Date:  2016-12-01       Impact factor: 4.520

4.  Disease behaviours of sows naturally infected with Taenia solium in Tanzania.

Authors:  Chiara Trevisan; Maria Vang Johansen; Ernatus Martin Mkupasi; Helena Aminel Ngowi; Björn Forkman
Journal:  Vet Parasitol       Date:  2017-01-16       Impact factor: 2.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.